Literature DB >> 6446431

Suppression of pokeweed mitogen-induced differentiation of human B cells by in vitro levamisole-treated T lymphocytes.

T Miyawaki, H Seki, N Moriya, T Nagaoki, M Kubo, N Okuda, N Taniguchi.   

Abstract

The generation of immunoglobulin-producing cells from human peripheral blood lymphocytes in pokeweed mitogen-simulated cultures was significantly suppressed by levamisole. Greatest suppression was observed when cells were incubated with levamisole at a concentration of 10(-6) M for 20 min or more prior to culture. Such suppression occurred when untreated as well as levamisole-treated B cells were co-cultured only with levamisole-treated T cells. Adding of levamisole-treated T cells to a combination of untreated autologous B and T cells resulted in the suppression of B cell differentiation. The results suggest that levamisole treatment of lymphocytes exerts suppression on pokeweed mitogen-induced B cell differentiation through its effect on T cell regulatory properties.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446431      PMCID: PMC1536956     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.

Authors:  B Ramot; M Biniaminov; C Shoham; E Rosenthal
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

Review 2.  Levamisole in the modulation of the immune response: the current experimental and clinical state.

Authors:  J Symoens; M Rosenthal
Journal:  J Reticuloendothel Soc       Date:  1977-03

3.  Cancer immunotherapy: focus on the drug levamisole.

Authors:  J L Marx
Journal:  Science       Date:  1976-01-09       Impact factor: 47.728

4.  Suppression by thymosin of pokeweed mitogen-induced differentiation of human B cells.

Authors:  R E Wolf; A L Goldstein; M Ziff
Journal:  Clin Immunol Immunopathol       Date:  1978-11

5.  Mitogenic responsiveness and monocyte-lymphocyte interaction of early and late rosette-forming cell populations of human peripheral blood lymphocytes.

Authors:  N Taniguchi; T Miyawaki; N Moriya; T Nagaoki; E Kato
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes.

Authors:  A S Fauci; K R Pratt; G Whalen
Journal:  Immunology       Date:  1978-11       Impact factor: 7.397

7.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

8.  Immunoglobulins on the surface of human lymphocytes.

Authors:  M Papamichail; J C Brown; E J Holborow
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

9.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

10.  Thymus-like activities of sulphur derivatives on T-cell differentiation.

Authors:  G Renoux; M Renoux
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  3 in total

1.  The role of the spleen in experimental autoimmune thyroiditis.

Authors:  A P Weetman; A M McGregor; D P Rennie; R Hassman; R Hall
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

2.  Inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures of T and B cells by levamisole in vitro and in vivo.

Authors:  P Hersey; K Ho; J Werkmeister; U Abele
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

3.  Quantitative histochemical studies of the effect of levamisole on splenic T-cells in thymectomized Bufo bufo larvae.

Authors:  C Garavini; M C Rossini; B Mantovani
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.